Carrington's DelSite Subsidiary Reports GelVac(TM) Formulation Suitable For Nasal Delivery And As Injectable After Reconstitution

... Carrington Laboratories, Inc. (Nasdaq: CARN) reported today that a presentation entitled "Immunoenhancing Effect of a Novel In Situ Gelling Polygalacturonate, GelSite(R) Polymer" was presented at the 4th International Conference on Vaccines, which met November 16-17, 2006 in Washington, D.C. The presentation was authored by scientists from DelSite Biotechnologies, Inc. [click link for full article] ...